Mastura Monif

Projects

Projects per year 2018 2020 2021 2022 2023 2024 2030

• 10 Active
• 14 Finished

Projects per year

Search results

• Finished

  Molecular biomarkers of autoimmune encephalitis.

  Wesselingh, R. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)), Griffith, S. P. (Chief Investigator (CI)) & Seery, N. (Chief Investigator (CI))

  1/01/24 → 31/12/24

  Project: Research

• Development of PET tracers to track MS disease activity and progression

  Haskali, M. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)), Vivash, L. (Chief Investigator (CI)), Jupp, B. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/08/23 → 31/07/24

  Project: Research

• The contribution of monocytes and P2X7 Receptor in Multiple Sclerosis relapse.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)) & Stankovich, J. (Chief Investigator (CI))

  2/02/22 → 31/12/23

  Project: Research

• A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER, PHASE 2 STUDY TO EVALUATE THE EFFICACY, SAFETY, AND PHARMACOKINETICS OF ROZANOLIXIZUMAB IN ADULT STUDY PARTICIPANTS WITH LEUCINE-RICH GLIOMA INACTIVATED 1 AUTOIMMUNE ENCEPHALITIS

  Monif, M. (Primary Chief Investigator (PCI))

  24/08/21 → 31/12/24

  Project: Research

• The role of monocytes and P2X7 Receptor in the pathogenesis of relapsing remitting multiple sclerosis flare: a translational study.

  Monif, M. (Primary Chief Investigator (PCI)) & Butzkueven, H. (Chief Investigator (CI))

  Multiple Sclerosis Research Australia (trading as National Multiple Sclerosis Research Foundation Limited)

  18/03/21 → 31/12/23

  Project: Research

• The contribution of monocytes and P2X7 Receptor in Multiple Sclerosis relapse.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)) & Stankovich, J. (Chief Investigator (CI))

  2/03/21 → 31/12/21

  Project: Research

• Immune phenotyping and Disease modifying treatments in MS – implications for treatment response and infection.

  Van Der Walt, A. (Primary Chief Investigator (PCI)), Monif, M. (Chief Investigator (CI)) & Butzkueven, H. (Chief Investigator (CI))

  1/01/21 → 31/12/21

  Project: Research

• MAGPIX

  Monif, M. (Primary Chief Investigator (PCI)), Hibbs, M. (Chief Investigator (CI)), Tarlinton, D. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  1/01/21 → 31/12/21

  Project: Research

• Polarization of immune cells by novel compounds

  Ali, I. (Primary Chief Investigator (PCI)), Jones, N. (Chief Investigator (CI)), Monif, M. (Chief Investigator (CI)) & Semple, B. (Chief Investigator (CI))

  Katholieke Universiteit Leuven (KU Leuven) (Catholic University of Leuven)

  13/07/20 → 12/09/21

  Project: Research

• Autoimmune Encephalitis - a rare and debilitating neurological illness affecting the Australian population. A study of the Australian Autoimmune Encephalitis Consortium.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)), Reddel, S. W. (Chief Investigator (CI)), Kalincik, T. (Chief Investigator (CI)), Tarlinton, D. (Chief Investigator (CI)), Seneviratne, U. (Chief Investigator (CI)), Kulkarni, J. (Chief Investigator (CI)), Buzzard, K. (Chief Investigator (CI)) & Taylor, B. V. (Chief Investigator (CI))

  1/06/20 → 31/05/25

  Project: Research

• The therapeutic role of P2X7 Receptor antagonism in human brain tumours

  Monif, M. (Primary Chief Investigator (PCI))

  1/01/20 → 2/02/21

  Project: Research

• CLADIN sub study. Effect of CLADribine on Innate Immune Response (CLADIN). MS Immunity Project.

  Monif, M. (Primary Chief Investigator (PCI)), Butzkueven, H. (Chief Investigator (CI)) & O'Brien, T. (Chief Investigator (CI))

  27/06/19 → 9/09/22

  Project: Research

• The role of microglia and P2X7 Receptor in human gliomas – a translational study

  Monif, M. (Primary Chief Investigator (PCI)), Drummond, K. J. (Chief Investigator (CI)), O'Brien, T. (Chief Investigator (CI)), Williams, D. A. (Chief Investigator (CI)) & Kan, K. (Chief Investigator (CI))

  Brain Foundation

  1/01/19 → 31/12/19

  Project: Research

• PhD Project: Altered Vitamin D responsiveness in Multiple Sclerosis Immune Cells.

  Butzkueven, H. (Chief Investigator (CI)), Van Der Walt, A. (Primary Chief Investigator (PCI)), Stankovich, J. (Chief Investigator (CI)), Jokubaitis, V. (Chief Investigator (CI)) & Monif, M. (Chief Investigator (CI))

  Roche Products Pty Ltd (trading as Roche Australia)

  16/10/18 → 1/01/20

  Project: Research